Sevoflurane Inhibits LncRNA HOTAIR-Modulated Stability of HK2 MRNA in a M6A-Dependent Manner to Dampen Aerobic Glycolysis and Proliferation in Lung Cancer

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2022 Jul 18

PMID 35845960

Authors

Xuefeng Sun

Qiyong Li

Ling Yang

Affiliations

Soon will be listed here.

Abstract

Previous studies have shown that sevoflurane has an inhibitory effect on tumor cells. So far, the effect of sevoflurane on hepatocellular carcinoma needs to be confirmed by more studies. HOX transcript antisense intergenic RNA (HOTAIR), a long noncoding RNA (lncRNA), has been shown to enhance cancer cell proliferation and medication resistance. The inherent importance and biological function of HOTAIR in the course of lung cancer (LC) is, however, poorly unclear. HOTAIR was shown to be highly elevated in LC cells in this investigation. Impairment of function trials with sevoflurane indicated that it has anticancer effects on LC cell growth, apoptosis, and aerobic glycolysis. In a mechanistic manner, HOTAIR was related to HK2 mRNA and promoted expression and constancy. Additional research revealed that HOTAIR coupled with hexokinase 2 (HK2) mRNA and favorably controlled its stabilization in a traditional-component way. By HK2, the LC enhancement role was mediated. In summary, our data show that HOTAIR promotes the synthesis and proliferation of LC glycogen by increasing the transcription of HK2, and HOTAIR is likely to be a potential treatment for LC patients.

Citing Articles

The N6-methyladenosine pattern of MAP3K7 mediates the effects of sevoflurane on macrophage M2 polarization and cervical cancer migration and invasion.

Huang L, Duan F, Dong X, Zhang Z Cent Eur J Immunol. 2025; 49(4):393-403.

PMID: 39944262 PMC: 11811724. DOI: 10.5114/ceji.2024.145307.

ZC3H13 knockdown enhances the inhibitory effect of sevoflurane on gastric cancer cell malignancy by regulating the N6-methyladenosine modification of the lncRNA DLX6-AS1.

Liu C, Chen Z Heliyon. 2024; 10(16):e35722.

PMID: 39220970 PMC: 11365301. DOI: 10.1016/j.heliyon.2024.e35722.

Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.

Dou Z, Ma X, Piao M, Wang J, Li J Transl Cancer Res. 2024; 13(6):3106-3125.

PMID: 38988908 PMC: 11231769. DOI: 10.21037/tcr-23-2401.

Knowledge mapping and current trends of m6A methylation in the field of cancer.

Zhu C, Yang J, Zhang C, Wang Y, Wang J Heliyon. 2024; 10(4):e26262.

PMID: 38434062 PMC: 10906179. DOI: 10.1016/j.heliyon.2024.e26262.

Sevoflurane Confers Protection Against the Malignant Phenotypes of Lung Cancer Cells via the microRNA-153-3p/HIF1α/KDM2B Axis.

Xiong K, Wu Z Biochem Genet. 2023; 62(5):3523-3539.

PMID: 38127172 DOI: 10.1007/s10528-023-10607-2.

References

Liang R, Li X, Li W, Zhu X, Li C . DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine. Biomed Pharmacother. 2021; 144:112202. DOI: 10.1016/j.biopha.2021.112202. View

Papaioannou D, Petri A, Dovey O, Terreri S, Wang E, Collins F . The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nat Commun. 2019; 10(1):5351. PMC: 6877618. DOI: 10.1038/s41467-019-13259-2. View

Li N, Meng D, Gao L, Xu Y, Liu P, Tian Y . Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression. Radiat Oncol. 2018; 13(1):210. PMC: 6201557. DOI: 10.1186/s13014-018-1153-4. View

Liberti M, Locasale J . The Warburg Effect: How Does it Benefit Cancer Cells?. Trends Biochem Sci. 2016; 41(3):211-218. PMC: 4783224. DOI: 10.1016/j.tibs.2015.12.001. View

Shen X, Shen P, Yang Q, Yin Q, Wang F, Cong H . Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways. J Cancer. 2019; 10(26):6502-6510. PMC: 6856901. DOI: 10.7150/jca.35098. View

Min F, Chu G . Long noncoding RNA PCAT-1 knockdown prevents the development of ovarian cancer cells via microRNA-124-3p. J Cell Biochem. 2019; 121(2):1963-1972. DOI: 10.1002/jcb.29431. View

Mao Y, Dong L, Liu X, Guo J, Ma H, Shen B . mA in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat Commun. 2019; 10(1):5332. PMC: 6877647. DOI: 10.1038/s41467-019-13317-9. View

Li Q, Song W, Wang J . TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2. Biomed Pharmacother. 2018; 109:1793-1801. DOI: 10.1016/j.biopha.2018.11.003. View

Paris J, Morgan M, Campos J, Spencer G, Shmakova A, Ivanova I . Targeting the RNA mA Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia. Cell Stem Cell. 2019; 25(1):137-148.e6. PMC: 6617387. DOI: 10.1016/j.stem.2019.03.021. View

10.

Weng H, Huang H, Wu H, Qin X, Zhao B, Dong L . METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA mA Modification. Cell Stem Cell. 2018; 22(2):191-205.e9. PMC: 5860916. DOI: 10.1016/j.stem.2017.11.016. View

11.

Deng X, Su R, Stanford S, Chen J . Critical Enzymatic Functions of FTO in Obesity and Cancer. Front Endocrinol (Lausanne). 2018; 9:396. PMC: 6077364. DOI: 10.3389/fendo.2018.00396. View

12.

Li Z, Weng H, Su R, Weng X, Zuo Z, Li C . FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N-Methyladenosine RNA Demethylase. Cancer Cell. 2016; 31(1):127-141. PMC: 5234852. DOI: 10.1016/j.ccell.2016.11.017. View

13.

Koukourakis M, Giatromanolaki A . Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy. Int J Radiat Biol. 2018; 95(4):408-426. DOI: 10.1080/09553002.2018.1490041. View

14.

Doaei S, Kalantari N, Mohammadi N, Izadi P, Gholamalizadeh M, Eini-Zinab H . Up-regulation of FTO gene expression was associated with increase in skeletal muscle mass in overweight male adolescents. Arch Med Sci. 2019; 15(5):1133-1137. PMC: 6764316. DOI: 10.5114/aoms.2019.87239. View

15.

Wang Y, Jiang X, Feng Z, Li X, Zhang W . Long noncoding RNA PCAT-1 accelerates the metastasis of pancreatic cancer by repressing RBM5. Eur Rev Med Pharmacol Sci. 2019; 23(17):7350-7355. DOI: 10.26355/eurrev_201909_18841. View

16.

Cao L, Zhang P, Li J, Wu M . , a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote mRNA stability in human cells. Elife. 2017; 6. PMC: 5739540. DOI: 10.7554/eLife.30433. View

17.

Yang S, Wei J, Cui Y, Park G, Shah P, Deng Y . mA mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019; 10(1):2782. PMC: 6592937. DOI: 10.1038/s41467-019-10669-0. View

18.

Jing P, Zhou S, Xu P, Cui P, Liu X, Liu X . PDK1 promotes metastasis by inducing epithelial-mesenchymal transition in hypopharyngeal carcinoma via the Notch1 signaling pathway. Exp Cell Res. 2019; 386(2):111746. DOI: 10.1016/j.yexcr.2019.111746. View

19.

Simioni C, Bergamini F, Ferioli M, Rimondi E, Caruso L, Neri L . New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances. Hematol Oncol. 2019; 38(1):22-33. DOI: 10.1002/hon.2678. View

20.

Su Y, Huang J, Hu J . mA RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer. Front Oncol. 2019; 9:1038. PMC: 6813557. DOI: 10.3389/fonc.2019.01038. View